Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Naganuma

Showing results (1-10 of 296) with videos related to

Pageof 30
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 12, 2020
[Colitis-associated cancer in ulcerative colitis -current status and problems for diagnosis]Makoto Naganuma
Immunological Medicine|April 30, 2019
Treatment with indigo naturalis for inflammatory bowel disease and other immune diseasesMakoto Naganuma
Journal of Gastroenterology|August 12, 2020
Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitisMakoto Naganuma
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 12, 2019
[Efficacy and safety of JAK inhibitors;including therapeutic positioning]Makoto Naganuma
Journal of Gastroenterology|December 14, 2024
Reply to "Severe ulcerative colitis: diagnostic criteria and therapy"Makoto Naganuma
Journal of Gastroenterology|April 5, 2018
Author's reply: can budesonide form be alterative treatment for ulcerative proctosigmoiditis?Makoto Naganuma
Journal of Gastroenterology|May 13, 2024
Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy"Makoto Naganuma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 15, 2007
[New therapeutic strategies for inflammatory bowel diseases]Toshifumi Hibi, Makoto Naganuma
Journal of Gastroenterology|May 8, 2002
Do immunosuppressants really work as maintenance therapy after the achievement of remission of severe ulcerative colitis?Makoto Naganuma, Toshifumi Hibi
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 7, 2009
[Current treatment for severe ulcerative colitis]Makoto Naganuma, Toshifumi Hibi
Pageof 30

Showing results (1-10 of 296) with videos related to

Sort By:
Pageof 30
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 12, 2020
[Colitis-associated cancer in ulcerative colitis -current status and problems for diagnosis]Makoto Naganuma
Immunological Medicine|April 30, 2019
Treatment with indigo naturalis for inflammatory bowel disease and other immune diseasesMakoto Naganuma
Journal of Gastroenterology|August 12, 2020
Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitisMakoto Naganuma
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 12, 2019
[Efficacy and safety of JAK inhibitors;including therapeutic positioning]Makoto Naganuma
Journal of Gastroenterology|December 14, 2024
Reply to "Severe ulcerative colitis: diagnostic criteria and therapy"Makoto Naganuma
Journal of Gastroenterology|April 5, 2018
Author's reply: can budesonide form be alterative treatment for ulcerative proctosigmoiditis?Makoto Naganuma
Journal of Gastroenterology|May 13, 2024
Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy"Makoto Naganuma
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 15, 2007
[New therapeutic strategies for inflammatory bowel diseases]Toshifumi Hibi, Makoto Naganuma
Journal of Gastroenterology|May 8, 2002
Do immunosuppressants really work as maintenance therapy after the achievement of remission of severe ulcerative colitis?Makoto Naganuma, Toshifumi Hibi
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 7, 2009
[Current treatment for severe ulcerative colitis]Makoto Naganuma, Toshifumi Hibi
Pageof 30